Hemodynamic effects of arotinolol in anesthetized dogs and its affinities for adrenoceptors in vitro
- PMID: 6202253
Hemodynamic effects of arotinolol in anesthetized dogs and its affinities for adrenoceptors in vitro
Abstract
Hemodynamic actions of arotinolol in anesthetized dogs and its effects on alpha- and beta-adrenoceptors were examined. Arotinolol produced dose-dependent decrease in mean blood pressure, heart rate, cardiac output, maximum rate of left ventricular pressure rise and coronary blood flow in a dose range of 1 microgram/kg-3 mg/kg. Total peripheral resistance (TPR) increased with arotinolol dose-dependently in a dose range of 1 microgram/kg-0.3 mg/kg, but at doses of 1 and 3 mg/kg the increase in TPR was less. Arotinolol at a dose of 10 micrograms/kg significantly inhibited the blood pressure and heart rate responses to isoproterenol. Propranolol at the same dose produced only a slight inhibition of these. Arotinolol at a dose of 3 mg/kg attenuated the pressor response to phenylephrine without any effect on the response to angiotensin-II in anesthetized dogs. Propranolol at the same dose produced only a slight inhibition of the response to phenylephrine. In the study of radioactive ligand binding assays, arotinolol showed high affinities for both beta 1- and beta 2-adrenoceptors. Arotinolol showed an affinity also for alpha 1-adrenoceptors which was comparable to the affinity of yohimbine. Thus, the present results support the idea that arotinolol possesses both alpha- and beta-adrenoceptors blocking effects.
Similar articles
-
Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.Arch Int Pharmacodyn Ther. 1984 Oct;271(2):249-62. Arch Int Pharmacodyn Ther. 1984. PMID: 6210068
-
Mechanism of the hypotensive effect of a new beta-adrenergic blocking drug, arotinolol (S-596) in anesthetized rabbits.Arch Int Pharmacodyn Ther. 1985 Oct;277(2):253-63. Arch Int Pharmacodyn Ther. 1985. PMID: 2415080
-
Effects of arotinolol on hemodynamics and adrenergically induced renin release and renal vasoconstriction.Arzneimittelforschung. 1988 May;38(5):671-7. Arzneimittelforschung. 1988. PMID: 2458109
-
A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):681-4. Br J Clin Pharmacol. 1976. PMID: 10948 Review.
-
Central vasopressor actions of angiotensin.Biochem Pharmacol. 1977 Jan 1;26(1):1-3. doi: 10.1016/0006-2952(77)90120-4. Biochem Pharmacol. 1977. PMID: 318834 Review. No abstract available.
Cited by
-
The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes.Cardiovasc Drugs Ther. 1991 Jun;5(3):561-76. doi: 10.1007/BF03029726. Cardiovasc Drugs Ther. 1991. PMID: 1678960 Review.